MET and pneumonitis: A recent retrospective cohort showed that six of seven patients who received MET inhibitors following ICI presented with an early grade ≥3 AE (4 transaminitis, 2 pneumonitis), leading to the permanent discontinuation of MET inhibitors in 3 of the six patients.20